Bipolar Disorder, characterized by mood swings from manic highs to depressive lows, is a complex psychiatric condition that requires nuanced understanding and care. The Journal of Clinical Psychiatry offers in-depth insights into bipolar disorder, from diagnostic challenges to evidence-based treatment strategies. Our expert editors ensure that content is comprehensive, relevant, and cutting-edge, providing psychiatrists with the tools they need to offer holistic care to those living with this challenging condition.
Bipolar Disorder
Recently published article about Bipolar Disorder
Recent JCP Articles on Bipolar Disorder
Original Research
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
March 13, 2024
Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric...
Recent PCC Articles on Bipolar Disorder
Narrative Review
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
January 30, 2024
While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
Featured Bipolar Disorder Research
Original Research
Pharmacist-Led Telehealth for People With Psychosis or Bipolar Disorder
January 29, 2024
A telehealth collaborative care program with psychiatric clinical pharmacists had strong patient participation and was associated with greater medication adherence and guideline-concordant preventive care.
Original Research
Antisuicidal Effects of Ketamine in Patients With Comorbid AUD
April 24, 2024
Intranasal ketamine induced rapid antidepressant effects versus placebo but did not significantly change suicidal ideation scores in patients with alcohol use disorder and suicidal ideation with past attempt.
Case Report
Caffeine Reduction Increases Serum Lithium Concentration
April 11, 2024
A patient with schizoaffective disorder was found to have supratherapeutic lithium serum concentrations following sudden caffeine reduction, and management with lithium dosage reduction precipitated exacerbation of psychiatric symptomatology.
